Dark
Light
System
Institutional Investment Manager
Redmile Group, LLC
Redmile Group, LLC (CIK: 0001425738) incorporated in Delaware, located at One Letterman Drive, San Francisco, CA. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q4)
Portfolio Summary: 50 holdings with a total value of $1,160,076,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 ARRAY BIOPHARMA INC COM 16,618,776 146,079,000 12.59%
2 SEATTLE GENETICS INC 1,520,904 80,258,000 6.92%
3 CLOVIS ONCOLOGY INC 1,620,355 71,976,000 6.20%
4 PENUMBRA INC COM 1,040,208 66,365,000 5.72%
5 AMICUS THERAPEUTICS INC 12,331,130 61,286,000 5.28%
6 ARIAD PHARMACEUTICALS INC 3,838,376 47,749,000 4.12%
7 INCYTE 451,987 45,321,000 3.91%
8 MOLINA HEALTHCARE INC 805,546 43,709,000 3.77%
9 GW PHARMACEUTICALS PLC 366,068 40,908,000 3.53%
10 PUMA BIOTECHNOLOGY 1,290,140 39,607,000 3.41%
11 Atara Biotherapeutics Inc 2,670,942 37,927,000 3.27%
12 NEURODERM LTD 1,560,819 34,650,000 2.99%
13 PROTHENA CORP PLC 653,725 32,157,000 2.77%
14 AGIOS PHARMACEUTICALS INC 738,451 30,816,000 2.66%
15 CENTENE CORP DEL 516,598 29,193,000 2.52%
16 XENCOR INC COM 996,100 26,217,000 2.26%
17 Oxford Immunotec Global PLC 1,701,049 25,431,000 2.19%
18 WAVE LIFE SCIENCES LTD 951,712 24,887,000 2.15%
19 EXPRESS SCRIPTS HLDG CO 338,800 23,306,000 2.01%
20 NANOSTRING TECHNOLOGIES INC 937,957 20,916,000 1.80%
21 ALDER BIOPHARMACEUTICALS INC 920,550 19,147,000 1.65%
22 NEVRO CORP 260,380 18,919,000 1.63%
23 CHARLES RIV LABS INTL INC 247,107 18,827,000 1.62%
24 CHIMERIX INC 3,345,959 15,391,000 1.33%
25 Audentes Therapeutics, Inc. 832,736 15,214,000 1.31%
26 PATHEON N V SHS 440,720 12,653,000 1.09%
27 ARRAY BIOPHARMA INC 3 06/01/2020 9,000,000 12,593,000 1.09% PRN
28 SYROS PHARMACEUTICALS INC 948,440 11,533,000 0.99%
29 ANTHEM INC 77,223 11,102,000 0.96%
30 EHEALTH INC COM 997,621 10,625,000 0.92%
31 BOSTON SCIENTIFIC CORP 459,505 9,939,000 0.86%
32 INVITAE CORP 1,065,002 8,456,000 0.73%
33 ProQR Therapeutics NV 1,578,174 7,733,000 0.67%
34 CYTOMX THERAPEUTICS INC COM 696,992 7,660,000 0.66%
35 Model N Inc 809,914 7,168,000 0.62%
36 ENDOLOGIX INC 1,206,894 6,903,000 0.60%
37 IRHYTHM TECHNOLOGIES INC COM ADDED 228,800 6,864,000 0.59%
38 VCA INCORPORATED 70,040 4,808,000 0.41%
39 SPECTRANETICS CORP 187,627 4,597,000 0.40%
40 GLOBAL BLOOD THERAPEUTICS IN COM 316,400 4,572,000 0.39%
41 DYNAVAX TECHNOLOGIES CORP 1,049,791 4,147,000 0.36%
42 FATE THERAPEUTICS INC COM 1,419,058 3,562,000 0.31%
43 RA PHARMACEUTICALS INC 180,310 2,739,000 0.24%
44 ACLARIS THERAPEUTICS INC COM 94,200 2,557,000 0.22%
45 Diplomat Pharmacy Inc 153,317 1,932,000 0.17%
46 ISHARES TR 4,500 1,194,000 0.10%
47 UNITEDHEALTH GROUP INC 1,820 291,000 0.03%
48 AURINIA PHARMACEUTICALS INC 36,743 77,000 0.01%
49 ADVERUM BIOTECHNOLOGIES INC 22,236 64,000 0.01%
50 CASTLIGHT HEALTH INC COM CL B 10,229 51,000 0.00%

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-17-000010, filed 2017.02.14).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.